News

Yungshin’s Cefaclor (Oral Suspension) Has Been Certified by FDA of the U.S. as a Standard Drug

Congratulations! Chairman of Yungshin Pharm Ind. Co. LTD Lee, Fang-Yu Was Awarded China Medical University Outstanding Alumni in Management Leadership and China Medical University College of Pharmacy Outstanding Alumni.

Yungshin’s Sterile Injection Plant Passed the Inspection of FDA of the U.S. without Deficiency

Yungshin’s Sterile Injection Plant Was Inspected by British MHRA (the Medicines and Healthcare Products Regulatory Agency)

Yungshin Took Over Active Pharmaceutical Ingredients (API) of JAC to Expand Generic Drugs in Japan

Yungshin Acquired 100% of Shares of Zoetis Biotech Manufacturing Limited to Improve Capacity for Animal Healthcare Products

J'FANCY BEAUT’E Press Conference

Recommendation of Authoritative Doctors in Aesthetic Medicine

Yung Shin Medical Museum Opened Officially to Promote Knowledge of Safe Medication

Yungshin’s Entecavir Tablet Was Approved by Ministry of Health, Labour and Welfare for Marketing in Japan in February 2017

Yungshin Actively Prepares Itself for International GMP Inspections to Drive Export